Press Releases

All Releases
View Summary Lonza and Biowa Sign License Agreements with FivePrime Therapeutics for Use of Their POTELLIGENT® CHOK1SV Cell Line for Therapeutic Antibody Development
Wednesday, June 13, 2012
PDF 12.7 KB Add to Briefcase
View Summary Five Prime Therapeutics Announces that Human Genome Sciences Files U.S. IND for HGS1036/FP-1039 FGF Ligand Trap
Monday, June 4, 2012
PDF 7.0 KB Add to Briefcase
View Summary Five Prime Therapeutics Announces the Promotion of Aron Knickerbocker to Senior Vice President and Chief Business Officer
Thursday, May 3, 2012
PDF 7.8 KB Add to Briefcase
View Summary Five Prime Therapeutics Announces Second Strategic Alliance With GlaxoSmithKline
Tuesday, April 17, 2012
PDF 7.4 KB Add to Briefcase
View Summary Five Prime Therapeutics Confirms Appointment of Lewis T. “Rusty” Williams as CEO and Announces the Appointment of Brian Atwood as Chairman of the Board
Monday, February 6, 2012
PDF 7.7 KB Add to Briefcase
View Summary FIVE PRIME THERAPEUTICS PROVIDES AN UPDATE ON ITS STRATEGIC DISCOVERY COLLABORATIONS WITH PFIZER AND GLAXOSMITHKLINE
Thursday, June 16, 2011
PDF 7.2 KB Add to Briefcase
View Summary FivePrime President & CEO named one of 150 Most Influential Women in Bay Area Business
Friday, April 29, 2011
PDF 4.7 KB Add to Briefcase
View Summary Dyax Corp. and Five Prime Therapeutics, Inc. Enter Into Research Agreement for Discovery of Therapeutic Antibodies
Tuesday, April 26, 2011
PDF 48.9 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. to Present at Future Leaders in the Biotech Industry Conference in New York
Thursday, April 7, 2011
PDF 6.1 KB Add to Briefcase
View Summary HUMAN GENOME SCIENCES AND FIVEPRIME THERAPEUTICS ANNOUNCE DEVELOPMENT AND COMMERCIALIZATION AGREEMENT FOR NOVEL ANTI-CANCER DRUG
Wednesday, March 16, 2011
PDF 13.0 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. to Present at Cowen and Company 31st Annual Health Care Conference
Monday, February 28, 2011
PDF 5.8 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. to Present at the 13th Annual BIO CEO & Investor Conference
Thursday, February 10, 2011
PDF 5.7 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. to Present at Lazard Capital Markets 7th Annual Healthcare Conference
Tuesday, November 9, 2010
PDF 6.5 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. Announces Relocation to South San Francisco
Tuesday, October 19, 2010
PDF 6.4 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. to Present at Upcoming 9th Annual BIO Investor Forum
Tuesday, September 28, 2010
PDF 6.0 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. Elects Franklin Berger To Its Board Of Directors
Monday, September 27, 2010
PDF 7.5 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. Announces Issuance of Key Patents in the U.S. and Europe Covering Its Lead Oncology Drug
Tuesday, September 21, 2010
PDF 6.6 KB Add to Briefcase
View Summary FIVE PRIME THERAPEUTICS, INC. ANNOUNCES STRATEGIC ALLIANCE WITH GLAXOSMITHKLINE TO DISCOVER INNOVATIVE BIOLOGICS FOR SKELETAL MUSCLE DISORDERS
Tuesday, August 3, 2010
PDF 8.3 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. and Fast Forward, LLC Collaborate to Speed New Treatments to People With Multiple Sclerosis
Tuesday, May 25, 2010
PDF 9.4 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. to Present at Upcoming BIO International Convention
Thursday, April 29, 2010
PDF 6.1 KB Add to Briefcase
Showing 141-160 of 173 Page: 1 ... 4 5 6 7 8 9  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

FPRX (Common Stock)

Exchange
NASDAQ
Price
29.01
Change (%)
0.00
Volume
N/A

Data as of 4:00 PM ET on Thursday, July 20, 2017
Minimum 20 minute delay
Refresh quote
Powered By eSignal, Inc.